Segui
Meritxell Pons
Meritxell Pons
Email verificata su ub.edu
Titolo
Citata da
Citata da
Anno
Epigallocatechin‐3‐gallate, a DYRK1A inhibitor, rescues cognitive deficits in D own syndrome mouse models and in humans
R De la Torre, S De Sola, M Pons, A Duchon, MM de Lagran, M Farré, ...
Molecular nutrition & food research 58 (2), 278-288, 2014
3332014
Patient-specific iPSC-derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson's disease
A di Domenico, G Carola, C Calatayud, M Pons-Espinal, JP Muñoz, ...
Stem cell reports 12 (2), 213-229, 2019
3122019
Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 …
R de la Torre, S de Sola, G Hernandez, M Farré, J Pujol, J Rodriguez, ...
The Lancet Neurology 15 (8), 801-810, 2016
2942016
Astrocyte deletion of Bmal1 alters daily locomotor activity and cognitive functions via GABA signalling
O Barca-Mayo, M Pons-Espinal, P Follert, A Armirotti, L Berdondini, ...
Nature communications 8 (1), 14336, 2017
1892017
Human DNA methylomes of neurodegenerative diseases show common epigenomic patterns
JV Sanchez-Mut, H Heyn, E Vidal, S Moran, S Sayols, R Delgado-Morales, ...
Translational psychiatry 6 (1), e718-e718, 2016
1682016
Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A
M Pons-Espinal, MM de Lagran, M Dierssen
Neurobiology of disease 60, 18-31, 2013
782013
Circadian glucocorticoid oscillations preserve a population of adult hippocampal neural stem cells in the aging brain
M Schouten, P Bielefeld, L Garcia-Corzo, EMJ Passchier, S Gradari, ...
Molecular psychiatry 25 (7), 1382-1405, 2020
612020
Synergic functions of miRNAs determine neuronal fate of adult neural stem cells
M Pons-Espinal, E de Luca, MJ Marzi, R Beckervordersandforth, ...
Stem Cell Reports 8 (4), 1046-1061, 2017
552017
MiR-135a-5p is critical for exercise-induced adult neurogenesis
M Pons-Espinal, C Gasperini, MJ Marzi, C Braccia, A Armirotti, A Pötzsch, ...
Stem Cell Reports 12 (6), 1298-1312, 2019
442019
Parkinson’s disease patient-specific neuronal networks carrying the LRRK2 G2019S mutation unveil early functional alterations that predate neurodegeneration
G Carola, D Malagarriga, C Calatayud, M Pons-Espinal, L Blasco-Agell, ...
npj Parkinson's Disease 7 (1), 55, 2021
252021
Functional implications of hippocampal adult neurogenesis in intellectual disabilities
M Pons-Espinal, MM de Lagran, M Dierssen
Amino Acids 45, 113-131, 2013
192013
Environmental enrichment induces epigenomic and genome organization changes relevant for cognition
S Espeso-Gil, AZ Holik, S Bonnin, S Jhanwar, S Chandrasekaran, ...
Frontiers in Molecular Neuroscience 14, 664912, 2021
182021
A new SWATH ion library for mouse adult hippocampal neural stem cells
C Braccia, MP Espinal, M Pini, DDP Tonelli, A Armirotti
Data in Brief 18, 1-8, 2018
172018
Dissecting the non-neuronal cell contribution to Parkinson’s disease pathogenesis using induced pluripotent stem cells
M Pons-Espinal, L Blasco-Agell, A Consiglio
Cellular and Molecular Life Sciences 78, 2081-2094, 2021
132021
Long-term labeling of hippocampal neural stem cells by a lentiviral vector
H Suh, QG Zhou, I Fernandez-Carasa, GD Clemenson Jr, M Pons-Espinal, ...
Frontiers in Molecular Neuroscience 11, 415, 2018
82018
Piwil2 (Mili) sustains neurogenesis and prevents cellular senescence in the postnatal hippocampus
C Gasperini, K Tuntevski, S Beatini, R Pelizzoli, A Lo Van, D Mangoni, ...
EMBO reports 24 (2), e53801, 2023
62023
The piRNA pathway sustains adult neurogenesis by reducing protein synthesis and cellular senescence
C Gasperini, K Tuntevski, R Pelizzoli, A Lo Van, D Mangoni, RM Cossu, ...
bioRxiv, 2020.09. 15.297739, 2020
52020
iPSC‐based modeling of THD recapitulates disease phenotypes and reveals neuronal malformation
A Tristán‐Noguero, I Fernández‐Carasa, C Calatayud, ...
EMBO Molecular Medicine 15 (3), e15847, 2023
32023
Immunosuppressive tocilizumab prevents astrocyte induced neurotoxicity in hiPSC-LRRK2 Parkinson’s disease by targeting receptor interleukin-6
M Pons-Espinal, L Blasco-Agell, I Fernandez-Carasa, A di Domenico, ...
bioRxiv, 2022.08. 23.504918, 2022
12022
MiRNA pharmaceutical compositions and therapeutic uses thereof
DDP Tonelli, MP ESPINAL
US Patent 10,792,298, 2020
12020
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20